These genetically engineered mouse model (GEMM) data, plus the high prevalence of ARID1A/RNF43 mutations in our cohort and other PDAC cohorts,10, 24 established that these two genes were bona fide tumor suppressor genes for pancreatic cancer. The gene discussed is RNF43; the disease is pancreatic neoplasm.